Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (461-470 of 528) with videos related to

Pageof 53
Sort By:
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Analysis of more than 400,000 women provides case-control evidence for <i>BRCA1</i> and <i>BRCA2</i> variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
British Journal of Cancer|June 7, 2012
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter studyA Jakubowska, D Rozkrut, A Antoniou, et al.
Human Molecular Genetics|September 6, 2011
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriersDavid G Cox, Jacques Simard, Daniel Sinnett, et al.
Nature Communications|May 24, 2025
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testingPaul D P Pharoah, Rachel T Palmieri, Susan J Ramus, et al.
Human Genetics|May 21, 2011
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersKate M Im, Tomas Kirchhoff, Xianshu Wang, et al.
Breast (Edinburgh, Scotland)|November 12, 2025
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancerAmandine Billaud, Gisella Figlioli, Clémence Mooser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Cancer Risks Associated With Germline <i>PALB2</i> Pathogenic Variants: An International Study of 524 FamiliesXin Yang, Goska Leslie, Alicja Doroszuk, et al.
Plos Genetics|November 10, 2010
Common genetic variants and modification of penetrance of BRCA2-associated breast cancerMia M Gaudet, Tomas Kirchhoff, Todd Green, et al.
Plos Genetics|April 22, 2017
Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics ConsortiumMaggie C Y Ng, Mariaelisa Graff, Yingchang Lu, et al.
Pageof 53

Showing results (461-470 of 528) with videos related to

Sort By:
Pageof 53
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Analysis of more than 400,000 women provides case-control evidence for <i>BRCA1</i> and <i>BRCA2</i> variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
British Journal of Cancer|June 7, 2012
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter studyA Jakubowska, D Rozkrut, A Antoniou, et al.
Human Molecular Genetics|September 6, 2011
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriersDavid G Cox, Jacques Simard, Daniel Sinnett, et al.
Nature Communications|May 24, 2025
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testingPaul D P Pharoah, Rachel T Palmieri, Susan J Ramus, et al.
Human Genetics|May 21, 2011
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersKate M Im, Tomas Kirchhoff, Xianshu Wang, et al.
Breast (Edinburgh, Scotland)|November 12, 2025
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancerAmandine Billaud, Gisella Figlioli, Clémence Mooser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Cancer Risks Associated With Germline <i>PALB2</i> Pathogenic Variants: An International Study of 524 FamiliesXin Yang, Goska Leslie, Alicja Doroszuk, et al.
Plos Genetics|November 10, 2010
Common genetic variants and modification of penetrance of BRCA2-associated breast cancerMia M Gaudet, Tomas Kirchhoff, Todd Green, et al.
Plos Genetics|April 22, 2017
Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics ConsortiumMaggie C Y Ng, Mariaelisa Graff, Yingchang Lu, et al.
Pageof 53